We examine the relation between testosterone, cortisol, and financial decisions in a sample of naïve investors. We find that testosterone level is positively related to excess risk-taking, whereas cortisol level is negatively related to excess risk-taking (correlation coefficient [r]: 0.75 and À0.21, respectively). Additionally, we find support for the dual-hormone hypothesis in a financial context. Specifically, the testosterone-to-cortisol ratio is significantly related to loss aversion. Individuals with a higher ratio are 3.4 times more likely to sell losing stocks (standard error [SE]: 1.63). Furthermore, we find a positive feedback loop between financial success, testosterone, and cortisol. Specifically, financial success is significantly related to higher post-trial testosterone and cortisol by a factor of 0.53 (SE: 0.14). Finally, we find that in a competitive environment, testosterone level increases significantly, leading to greater risktaking than in noncompetitive environment. Overall, this study underscores the importance of the endocrine system on financial decision-making. The results of this study are relevant to a broad audience, including investors looking to optimize financial performance, industry human resources, market regulators, and researchers.
Introduction
To what extent does physiology impact financial decisionmaking? Specifically, how do hormones in general, and the interplay between testosterone and cortisol, affect financial decisions? Finance professionals and academics alike have typically ignored these questions. This study helps to answer these questions from an endocrinology perspective. Specifically, we examine the relation between the sex hormone testosterone and the stress hormone cortisol on investment decision-making. 1 The current body of research (summarized below) suggests that these hormones cross the blood-brain barrier and play a key role in brain areas involving risk and reward. Specifically, testosterone is thought to exert a significant influence on cognitive processes dealing with stimuli interpretation, risky behavior, and confidence (Coates et al., 2010) . Therefore, it is thought that testosterone impacts financial decisions and outcomes. However, few studies exist about the relation of testosterone and financial decisions, and their results are inconclusive (Apicella et al., 2015) . Similarly, medical studies show that cortisol plays a key role in brain areas associated with risk and reward. Since it is widely held that stress is rampant among finance professionals, such as traders and fund managers (Kahn and Cooper, 1990; Jones et al., 2003; Oberlechner and Nimgade, 2005) , it is likely that cortisol, like testosterone, have a significant influence on financial decisions and outcomes (i.e., McEwen and Sapolsky, 1995; Sapolsky, 1996; Dominique et al., 1998; Lupien et al., 2009) . Unfortunately, studies about the role of stress on financial choices and outcomes are scant, and the evidence so far is inconclusive.
The dual-hormone hypothesis postulates that cortisol regulates the effects of testosterone on behavior. For example, high testosterone level in tandem with low cortisol level is associated with a biological predisposition for social aggression, presumably by suppressing cortical and subcortical neural communications that control socially aggressive tendencies (i.e., Van Honk et al., 2010) . More broadly, imbalance in the ratio of testosterone-tocortisol is associated with social aggression (Terburg et al., 2009) , social dominance (Mehta and Josephs, 2010) , anger (Hermans et al., 2008) and a plethora of other social risky behaviors (Barel et al., 2017) . Mehta et al. (2015) use the Balloon Analog Risk Task to study the dual-hormone hypothesis in an economic setting. Specifically, participants earn money for every time they decide to add increasing amount of air into a balloon. When a random threshold is met, the balloon explodes, and participants lose all the money made until that point. The authors find that testosterone level is positively related to increased risk-taking (i.e., pumping greater amount of air into the balloon), but only when cortisol level is low. Overall, the literature suggests that the dual-hormone hypothesis may apply in economic settings. To our knowledge, we are the first to study the dual-hormone hypothesis in a financial setting, specifically, during investment tasks.
The present study represents one of the first comprehensive efforts to understand the isolated and combined role of testosterone and cortisol on investment decisions and outcomes. Given the nascent state of the literature, it is still unknown whether testosterone, stress, or their interaction influence every kind of financial task (i.e., long-term investing, day-trading, and gambling), or if said influence is only present during certain conditions, such as a competitive environment (Schipper, 2014) . The related literature suggests that cognitive biases lead to irrational choices that can affect financial performance, such as low portfolio diversification (French and Poterba, 1993) , overconfidence (Barber and Odean, 2000) and the disposition effect (Dhar and Zhu, 2006) . Additionally, the literature suggests that testosterone and cortisol modulate cognitive biases and may influence financial decisionmaking by shifting economic utility functions, confidence levels, and/or risk preferences, through their effect on the brain's nucleus accumbens. As a part of the dopamine system, the nucleus accumbens is associated with pleasure and irrational risk-seeking behavior (Kuhnen and Knutson, 2005) . 2 For example, evidence of the "rewarding" property of testosterone is found in addiction studies of humans taking anabolic steroids (Kashkin and Kleber, 1989) . This rewarding property is thought to be due to the effects of testosterone and its two metabolic byproducts (dihydrotestosterone (DHT) and estradiol) on the nucleus accumbens, causing an increase in dopamine release (Frye et al., 2002) . Overall, the relation between testosterone, cortisol and affect suggests that these hormones may modulate financial cognitive errors, given that many economic biases involve emotions (Yuen and Lee, 2003; Lerner et al., 2004; Nofsinger, 2005) . In this study we treat the above suggestions as hypotheses, and examine the nature of the relation between testosterone, cortisol, and financial decisions and outcomes. The question of how testosterone and cortisol influence financial decision-making is perhaps one of the most difficult questions in this line of research because it involves understanding the biochemical mechanism of hormonal action in the brain. However, this study addresses the question from a behavioral perspective, linking hormone level to observable financial decisions and the resulting outcomes. Few studies have examined the link between testosterone (Coates and Herbert, 2008) and cortisol (Coates et al., 2010) and investment decision-making. Said studies provide a benchmark for comparison. However, our study differs from those papers in the following key respects: First, we analyze the relation of testosterone and cortisol in tandem (i.e., the dual-hormone hypothesis) and in isolation due to cortisol's influence on testosterone. Second, we examine the relationship between testosterone, cortisol, and financial decisions made under non-competitive and competitive environments. Third, we use a sample of male and female naïve investors, whereas the aforementioned papers employ a small sample of male professional traders. As such, the results of the present study have a more straight-forward application to a broader range of investors. Fourth, this study is free of trader selection bias, as we do not exclude subjects based on their trading skills or lack thereof. Such bias occurs in Coates and Herbert (2008) and Coates et al. (2010) because traders are typically pre-screened prior to being hired, or let go if they prove unsuccessful. 3 Finally, we examine the potential feedback loop between performance and hormone level. It has been suggested by other studies that certain economic tasks, such as poker tournaments, may impact physiological processes (Steiner et al., 2010) . We aim to show that said feedback exists even in naïve traders, which is akin to showing a link from the stock market back to investor. Such feedback mechanism would be a critical component of feedback models of stock market bubbles, yet little research has been conducted in this regard.
In this study, we investigate the role of testosterone, cortisol, and the dual-hormone hypothesis on financial choices and outcomes during two single-decision points, portfolio formation (asset allocation) tasks, and one multi-point portfolio rebalancing task. These tasks are akin to long-term investing in practice, because (as explained below) we make use of realistic financial trading simulation software. We find that higher levels of testosterone increase financial risk-taking, whereas higher levels of stress decrease financial risk-taking and portfolio expected returns. Additionally, cortisol is negatively related to portfolio diversification, which translates into greater exposure to unsystematic risk. Therefore, the positive relation between testosterone and risk-taking in social settings (i.e., social decisions) seems to be lacking in financial decisions, presumably due to the significant effects of cortisol levels. To this end, the results show that higher testosterone levels coupled with lower cortisol levels influence the selection of portfolio risk. Specifically, subjects undertake greater risk than necessary in order to meet the desired investment goal, not just to achieve a minimum required rate of return, but purposely done in order to perform significantly better than their peers. These results are consistent with the dual-hormone hypothesis that testosterone is only associated with increased financial risk-taking when cortisol levels are low. The results also show that subjects with higher testosterone to cortisol ratios are more likely to sell losing stocks, showing that the dual hormone hypothesis plays an important role in investment biases, especially the disposition effect. Finally, our results support the hypothesis that a feedback loop exists between financial decision-making and hormone activity. Specifically, we find that testosterone levels rise significantly in subjects who outperform their peers. Pre-trial levels of testosterone and cortisol influence financial decisions. In turn, the outcome of said decisions impact post-trial hormone levels, which influence future financial decisions. As such, our results show that economic models of asset valuation should consider the dynamic relation that exists between endocrine processes and financial decisions.
The remainder of this paper is organized as follows. Section 2 reviews the literature on the influence of testosterone and cortisol on financial decision-making. Section 3 describes our methodology and experiment. Specifically, we discuss our subjects, the trials or tasks, investment simulations, and saliva testing. Section 4 reviews the results for the first asset allocation task. The results 2 Dopamine is the major neurotransmitter of the reward system of the brain, which includes the ventral tegmental area, the nucleus accumbens, the amygdala, the hippocampus, and the medial prefrontal cortex. Rewarding experiences such as food, sex, and drugs lead to the release of dopamine, providing feelings of enjoyment and motivating the reinforcement of these activities. Bressan and Crippa (2005) provide a basic review of the dopamine system and its role in reward and pleasure.
3 It is common practice to put applicants through trading simulations and trial periods before hiring them as traders.
from the second asset allocation task are covered in Section 5. The final trial, the rebalancing task, is discussed in Section 6. We conclude with a discussion of the overall results in Section 7.
2. Literature and discussion of factors affecting decisionmaking
Testosterone and financial decision making
Only a few studies have addressed the effect of circulating testosterone levels on financial decision-making, leaving much to be explored. The literature on the relation of testosterone to financial decision-making is concentrated in a few recent studies. Coates and Herbert (2008) measure morning (11:00 a.m.) and afternoon (4:00 p. m.) testosterone levels in a small group (n = 17) of male floor traders for eight consecutive business days under real working conditions and find that traders achieve a significantly greater daily profitability (profit-and-loss level, or P and L) on days when their morning testosterone level is above their overall median level over the course of the study. These results indicate that morning testosterone levels might partially predict the direction of daily profitability in traders. However, they only compare how higher personal testosterone levels influence investors trading, and do not examine the impact of how overall testosterone levels influence decision making. Additionally, Nadler et al. (2017) exogenously administer testosterone in male traders to examine the impact of testosterone on trading behavior and asset price bubbles. Their results indicate that traders who received exogenous testosterone bid higher amounts for stock prices, which creates mispricing resulting in larger and longerlasting bubbles. Coates and Herbert (2008) present some evidence of the effect of testosterone on financial profitability during trading, providing a partial answer to the question of how testosterone affects financial outcomes. However, they do not find a relation between testosterone and financial risk taking. This finding (or rather lack of) is an outlier, given the empirical evidence linking testosterone to a variety of economic risk taking (Van Honk et al., 2004; Apicella et al., 2008; Stanton et al., 2011b) and social risk-taking behaviors (Dabbs et al., 1987; Mazur, 1995; Middleman and DuRant, 1996) .
However, not all studies find that testosterone is related to increased risk taking (i.e., Sapienza et al., 2009; Goudriaan et al., 2010) . Stanton et al. (2011b) propose that the inconsistent results from studies examining the relation between testosterone and economic risk might be due to possible nonlinear effects of testosterone on economic risk as they find that intermediate levels of testosterone, relative to other subjects, were found to be more risk-and ambiguity-averse compared those with low and high testosterone levels. Additionally, given that the dual-hormone hypothesis postulates that cortisol regulates the effects of testosterone on behavior, one explanation for the inconsistent results could be due to the omission of examining testosterone levels in tandem with cortisol levels. The inconsistent results found throughout the literature could also be due to the fact that studies use a variety of different tasks to measure economic risk, use either laboratory or real-life settings, examine active choices or survey responses, measure either endogenous or exogenously manipulated levels of testosterone, and/or include either one or both genders.
The second digit finger to the fourth digit finger ratio 2D:4D is directly related to the amount of in utero testosterone exposure. 4 Coates et al. (2009) measure the 2D:4D ratio of 44 male highfrequency traders and find it to be predictive of the traders' P&L levels over a 20-month period. Therefore, the results suggest that prenatal testosterone levels are associated with the long-term profitability of high-frequency traders. Moreover, Cronqvist et al. (2015) use a sample of more than 35,000 individuals listed in the Swedish Twin Registry and find that the 2D:4D ratio leads to an increased percentage of their portfolio invested in equity compared to debt, as well as the volatility of the portfolios suggesting that testosterone levels are related to portfolio risk taking. Similarly, Teixeira et al. (2015) find that the 2D:4D ratio is inversely related to myopic loss aversion, displaying a preference for more risk.
However, the 2D:4D ratio does not always provide consistent results with circulating levels of testosterone. Nave et al. (2017) find that exogenous testosterone is inversely related to correct answers on the Cognitive Reflection Test, suggesting that higher testosterone levels are related to poor and impulsive decisions. Conversely, Bosch-Domènech et al. (2014) show that individuals exposed to higher amounts of testosterone in utero have more correct answers in the Cognitive Reflection Test. Therefore, while some research shows that prenatal testosterone is related to increased financial risk taking, it is possible that blood circulating testosterone levels have a different impact. As such, it is imperative to examine how endogenous testosterone levels impact investment decision making. Four important issues that remain poorly understood are: 1) How does testosterone affect financial outcomes (such as investment risk and expected return)? 2) Is testosterone related to behavioral biases like trend following or loss aversion? 3) Does financial trading impact testosterone levels? 4) Does testosterone have a different impact on financial decision making in males and females. By understanding the influence of testosterone on these topics can help investors and traders make better financial decisions that lead to higher returns.
Stress and financial decision-making
Occupational stress is particularly high among finance professionals (Jones et al., 2003) , and it can result in behavioral problems, such as mental disorders (Dias, 1997) and elevated alcohol consumption (Kahn and Cooper, 1990) . Oberlechner and Nimgade (2005) surveyed a large sample of foreign exchange traders (n = 326), showing that "pressure to achieve the profit goal" is reportedly the greatest source of stress, followed by "long working hours" and "time pressure." These results are not unexpected, and they do not provide finance professionals with useful solutions. For one, the sources of stress are part of the job requirements for traders; therefore, they cannot be easily mitigated. Additionally, self-reported information fails to address stress sources that are outside of an individual's awareness. For example, Lo and Repin (2002) show that traders exhibit changes in heart rate, blood pressure, and skin conductance concurrently with transient market events. Such instinctual physiological responses to financial stimuli are consistent with the experience of stress. Therefore, biological markers of stress, such as cortisol levels, provide a superior method to study the relationship between stress and financial decision-making. Coates et al. (2010) examine the relation of salivary cortisol (Sal-C) to financial performance in a small sample of male floor traders (n = 17). The authors find no evidence that cortisol levels are related to trading gains or losses (P&L) or portfolio risk taking. However, their results suggest that cortisol levels have a significant positive linear relation to standard measures of risk, such as the variance of profits and the volatility of the market. It makes sense that volatility in markets and profits would cause stress and this is being picked up in cortisol levels. Additionally, some studies show 4 Testosterone is an important hormone for the body's formation in utero. Higher exposure to prenatal testosterone leaves measurable impacts on the body. Examples of these body markers are: (1) the ratio between the length of the second and fourth fingers (2D:4D) is smaller for people that were exposed to higher prenatal testosterone, and (2) more testosterone leads to higher masculinity of facial features. the opposite relation between stress and risk taking as described by Coates et al. (2010) . For example, Van Honk et al. (2003) show that cortisol levels correlate positively with risk aversion (instead of risk taking) in subjects playing the Iowa Gambling Task (IGT). Similarly, Kandasamy et al. (2014) find that subjects who are administered cortisol during a period of eight days exhibit greater levels of risk aversion than a control group. These inconsistencies in the literature make our study more relevant.
One explanation for the lack of results in Coates et al. (2010) is that individual professional traders should also be able to cope with trading-related stress better than the average individual investor. Note that the lack of a relationship between cortisol levels and trader P&L levels in the Coates and Herbert (2008) sample might very well be the result of the superior stress-coping skills of individuals in their sample. Due to the limited amount of research on cortisol and financial decision making, it is imperative to examine how cortisol levels impact investment decision making. Three important issues that remain poorly understood are: 1) How does cortisol affect financial outcomes (such as investment risk and expected return)? 2) Is cortisol related to cognitive errors such as behavioral biases? 3) Does financial trading impact cortisol levels? By understanding the influence of cortisol on these topics can help investors and traders make better financial decisions that lead to higher returns.
Methods
This study follows a similar methodology as other studies on the relation of endogenous (i.e., circulating) testosterone and cortisol levels to economic behavior. That is, subjects provide demographic information as well as a saliva sample prior to the financial tasks that are used to measure their morning baseline levels of testosterone and cortisol. After subjects provide the initial saliva sample, they engage in three financial trials using trading and investment simulation software. A second saliva sample is obtained at the end of the trials.
Subject recruitment and preparation
In order to utilize participants that possess a superior knowledge base in finance (as compared to the average person), graduate students were recruited from the Masters in Finance program's financial software course, in which they learn to use the financial trading simulation application Rotman Interactive Trader 2.0 (RIT 2.0).
5 Table 1 shows the sample statistics of the participants. 48 students pursuing their Masters in Finance degree were recruited for the sample. However, several students dropped the course before the simulations took place, two did not provide saliva samples, and the computer system did not capture one student's performance, which leaves a sample of 39 graduate students. Panel A identifies the final sample comprised of 12 women (31%) and 27 men (69%). The cultural make-up of the participants includes 12 who identify as Asian, 3 as Black, 17 as Hispanic, and 7 as Caucasian. Panel B shows that the average age of the participants is 27.4 years old, with a median of 25.3. More than half of the participants have no real-life investing experience.
In order to ensure that participants were proficient users of RIT 2.0, the experiment was scheduled at the end of the course. After the experiment was concluded, students were provided a questionnaire that asked to rate their comfort with the RIT 2.0 software, with more than half of the sample rating their comfort being 4 out of 5 as shown in Table 1 . Participants were given access to the simulation case descriptions employed in the study on the course website several weeks prior to the trial. Therefore, participants who were interested in performing well in the trial prepared by reading the cases and using the accompanying Excel spreadsheet to understand the cases in advance. There were two incentives for the participants; a monetary reward and a grade impact. The top three risk-adjusted performances received the traditional monetary incentive. 6 James and Isaac (2000) claim that using tournament incentives may be problematic. However, Kempf and Ruenzi (2008) show that tournament incentives are widely utilized in the financial industry, such as mutual fund families, and are therefore used in this simulation to recreate real working conditions in the financial industry. Thus, the second incentive was that their overall risk-adjusted performance could influence their course grade by up to one-third of a grade, e.g., B to B+. 
Trial
One week prior to the trial, participants were given a printout with detailed preparation instructions, which can be seen in Appendix A. This same handout was posted to the Blackboard Learn online course interface. The trial was conducted in the morning since testosterone follows a circadian rhythm, with the highest baseline levels exhibited during the morning hours.
Participants were instructed to arrive at the computer lab facility by 8:15 a.m. on the day of the trial, and to refrain from eating or drinking anything after 8:00 a.m. on that day, in order to provide a clean saliva sample. The trial began at 8:20 a.m. and lasted for one hour. Saliva samples were collected immediately prior to the trial, using a standard procedure discussed below. Granger et al. (2004) explain that several factors can limit the validity of salivary testosterone measurement, therefore the recommendations and suggestions from Granger et al. (2004) . With the permission of the instructor, study participants were recruited during the second week of the course. Potential participants were then provided a general description of the study and told what was expected of them, including that they would be expected to provide saliva samples. However, participants did not know what was being tested for in the saliva. 6 In total, six people received gift cards. 7 During the week before the trial, participants were reminded via an online announcement to review the study instructions and simulation cases, and they were asked to take a short online questionnaire to test their knowledge about the instructions and the simulation cases. Thus, every measure was taken to ensure that participants knew in advance what to expect during the trial. By the day of the trial, 37 (95%) participants had completed the online questionnaire. The median score is 5 (out of 6 questions), showing that the majority of participants were very familiar with the trial instructions and the simulation cases.
are used to overcome these issues. The procedure can be summarized as follows: Each subject was provided with a Salivette 1 test tube at the time of collection. All subjects were given sugar-free gum in order to stimulate saliva production. At least two minutes after chewing the gum subjects produced a minimum sample of 3 mL of saliva, which they inserted into the test tube. The test tubes were sealed and refrigerated within 48-72 h of collection at À20 C until analysis. The time-span between saliva collection and refrigeration does not influence hormonal concentration, as saliva testosterone and cortisol can last up to five days on average before degradation. After the trials, the saliva samples were transported to the University lab facility, where the salivary testosterone (Sal-T) and cortisol (Sal-C) levels were measured via mass spectrometric analysis. 
Investment simulations
Immediately following the collection of the saliva sample, participants engaged in three financial tasks using RIT 2.0.
9 The first two tasks involve investment asset allocation decisionmaking (i.e., long-term financial choices), whereas the third task involves long-term investment decision-making with the prospect of rebalancing the portfolio. The first two investment tasks are identical to each other, for which Rotman categorizes as "Diversification." The participant is asked to allocate portfolio funds among investment assets with different return and risk characteristics. Henceforth, these tasks are referred to as the Portfolio Allocation 1 (PORT1) and Portfolio Allocation 2 (PORT2) tasks.
During the diversification tasks, subjects have an endowment of $500,000 to invest in a portfolio of assets. The stated goal is that the portfolio must grow to $1.5 million by the end of the simulated 20-year time horizon. Therefore, this task is a straightforward goaloriented investment task. The subjects can choose from five Electronic Trading Funds (ETFs) of different expected (historical) returns and volatilities (shown in Table 3 ), which are known to the participants. Each participant made asset allocation decisions during the first task, PORT1. After making their allocation choices in the ETFs (or in CASH for funds not invested), each of the ETF prices evolved as a random walk with positive drift and standard deviation as given by their historical return and volatility, respectively. We are interested in examining how testosterone and cortisol influence risk aversion in this first diversification task. Also, the price path of one trial has no impact on the price path of another trial and can be significantly different, just as the previous result of a coin toss has no impact on the distribution of outcomes of the next coin toss.
For the second task, PORT2, participants see the results of the first task (PORT1) simulations. They see whether they met their goal and their ranking within the group. The monetary reward is based on the performance ranking of each task separately. 10 The knowledge of their ranking after the first task increases the competitive component for PORT2 as those who performed poorly on PORT1, must improve in PORT2. The portfolio return outcome from PORT1 should not have an impact on the next independent decision task (PORT2) because it is the same task. However, people frequently make the cognitive error of overweighting recent and irrelevant information. This recency effect (Nofsinger and Varma, 2013) , extrapolation bias (Bailey et al., 2011) , and gambler's fallacy (Rabin, 2002) are common behavioral finance biases. Therefore, we are interested in examining the impact of testosterone and cortisol levels in decisions to change the allocation for the PORT2 task after considering the results of the PORT1 simulation and learning the competitive aspect of the trials. The third task of the diversification trial involves the same initial asset allocation task, but also includes three portfolio rebalancing tasks (at years 5, 10, and 15). In this case, the portfolio outcome during each five-year simulation period does provide relevant information for rebalancing. Specifically, the value of the portfolio after each simulation is an important determinant in choosing an appropriate asset allocation to best achieve the stated goal to accumulate $1.5 million within 20 years. However, the actual performance of each asset during a simulation has no impact on their return in the next five-year period. Therefore, those results do not provide useful information to the participants. We examine the role of testosterone and cortisol in the portfolio rebalancing decisions.
Testosterone and cortisol measurement
Free (unbound) saliva testosterone (Sal-T) and cortisol (Sal-C) measurement is the preferred method to study circulating (i.e., blood) levels of testosterone and cortisol in the body because of the non-invasiveness of the procedure used to collect the saliva as compared to serum, as subjects are more likely to participate in a study using saliva instead of having to give blood.
However, unlike serum analysis, there is no standard way to measure the Sal-T concentration. Therefore, benchmarking is constrained by the particular procedure used to determine the concentration of Sal-T. In other words, it is difficult to compare absolute levels of Sal-T across studies, because of the different methodologies used to test for concentration. Only within study comparisons are useful as they all use the same procedure. Therefore, we let the sample statistics dictate what constitutes high, intermediate, and low levels of Sal-T in subjects. Another aspect of testosterone measurement to consider is the fact that testosterone, being the primary male sex hormone, is significantly higher in males than in females. In this sample, the mean Sal-T concentration was 30.0 pg/mL (SD = 17.0) in men and 7.4 pg/mL (SD = 9.1) in women. Stanton et al. (2011a) obtains mean salivary testosterone levels of 86.5 pg/mL (SD = 26.0) for men and 14.2 pg/ mL (SD = 7.0) for women. These levels are very different from the ones in this study, illustrating the difficulties in benchmarking Sal-T using different protocols and results from other studies. Due to 8 The procedure for mass spectrometric analysis can be summarized as follows:
To 1000 mL of saliva add both methanol Internal standard (Testosterone D 3 ) 1 ng; Cortisol-D 4 2 ng/100 mL. The samples are mixed with 4 mL of ethyl acetate, agitated for 15 min, and then centrifuged at 3000 rpm for 10 min. After the aqueous layer is frozen, the ethyl acetate layer is isolated. The solution is evaporated using a centrifugation evaporator. The extract is dissolved in 100 mL of 70% acetonitrile, and 10 mL of this solution is injected into the LC/MS/MS system. A parallel solid phase extraction (SPE) process using 1 mL 30 mg HLB cartridges is used instead of organic extraction. Here 1000 mL of the saliva sample is used, fortified with the corresponding internal standard and centrifuged at 3000 rpm. The supernatant is subject to SPE analysis using a mix of water and methanol, and the final methanolic extract is evaporated and reconstituted in the mobile phase for further mass spectrometric analysis. Simultaneous Testosterone, Testosterone-D 3 , Cortisol and Cortisol Dd 4 are determined using selective reaction monitoring (SRM) of the following transitions (m/z): 289.3 ! 97.3, 292.3 ! 97.3, 363.3 ! 327.1, and 367.3 ! 331.3, respectively. For quantification purposes, at least five levels of calibration are use in the pg/mL range, using an internal standard. 9 The cases were developed by the Rotman Finance Lab to be used with the RIT simulation software. Case descriptions are available for download from at the Lab's website for subscribers. Additionally, instructors have access to the case solutions and to the master Excel spreadsheets that allow each case to be tailored as needed.
the natural gender difference in testosterone level, we convert individual raw Sal-T levels to z-scores relative to the Sal-T distribution for the gender of the individual. This technique is employed by other studies that use a sample of mixed genders (e.g., Mehta et al., 2008) . The Sal-T z-scores are used for all the analyses. We do not convert individual raw Sal-C levels to z-scores as the literature shows no gender differences for cortisol levels, nor its neural effect. The mean Sal-C concentration in the sample is 6.31 nmol/L (SD = 5.64). There is no benchmark to compare these levels since the Sal-C measurement is strongly related to the particular technique employed similar to Sal-T. Even studies that measure Sal-C at the same time of day present significantly different Sal-C concentrations. For example, Laudat et al. (1988) measure Sal-C at the same time of day as the present study. However, their sample exhibits a mean Sal-C level of 15.5 nmol/L (SD = 0.8), which is much higher than the mean Sal-C of subjects in the present study. In fact, Laudat et al. (1988) show that subjects with adrenal insufficiency (i.e., abnormally low levels of cortisol) have a mean Sal-C level of 7.5 nmol/L (SD = 0.4), which is more congruent with the results of this study. Therefore, if we compare the Sal-C from this study with theirs, it would inaccurately suggest that the subjects in this study suffer from abnormally low levels of cortisol that would require immediate medical attention. Table 2 presents the correlation table of the independent variables used in the analysis. The results show that testosterone and cortisol levels have a 52% correlation to each other. While Table 2 discloses elevated correlation levels between some independent variables, the Variance Inflation Factor (VIF) determines that there are no multicollinearity issues with the models. Table 3 shows the sample statistics for the first portfolio allocation task. Participants begin with $500,000 in cash and are given the goal of concluding the 20-year simulation period with at least $1.5 million, which means they need to earn an annualized return of at least 5.65%. They are given the six choices of assets and their expected (historical) returns and volatility is shown in Table 3 , Panel A. For example, the HOME (domestic equity) asset return in the simulation will be randomly drawn from a distribution that has an expected return of 8.5% and a standard deviation of 18%. The riskiest asset is GROW (emerging market equity), which has an expected return of 13% and a volatility of 30%. The other assets are BOND (domestic debt), MINE (global commodities), MMKT (global money markets), and CASH. Note that CASH offers no return whereas MMKT offers a low return with nearly no risk. The participants know the expected return from the ETF distribution and its standard deviation. Additionally, they know whether correlations between each ETF is high, low, or zero, but they are not aware of the exact correlations between the asset returns.
First portfolio allocation task analysis

Asset allocation choices
The average allocation of the 39 portfolios into HOME is nearly 22%. The average allocation to the GROW asset is 24%. Allocations to BOND, MINE, MMKT, and CASH are 12.8%, 13.8%, 7.0%, and 20.5%, respectively. Panel B shows that most of the portfolios are diversified into at least five of the six assets.
The participants did select portfolios that have an expected return, on average, exceeding the minimum need of 5.65%, with the average expected portfolio return of 6.53% and standard deviation of 2.54%. Measuring the risk selected by the participants is not straightforward. If the subjects knew the exact correlation between assets, they could compute the portfolio volatility using the historical volatilities of the assets, the covariance, and their allocation to each asset. However, they do not know the exact correlations, as they only know if the correlation between assets is high, low, or zero. Therefore, we use estimates of portfolio risk using information known at the time of the decision. We can also consider the expected return to be a measure of risk based on the fundamental finance concept of the positive relation between expected return and risk for a diversified portfolio. Next, we compute an average volatility like the expected return computation by employing volatility in place of return,
where d x signifies the fraction of the portfolio invested in asset x.
Panel C of Table 3 shows that the average AVE VOL for the portfolios is 14.45%, with a standard deviation of 5.74%. Lastly, the extent of diversification attempted by the participants can be considered a measure of risk, since the participants know that diversification reduces risk. We use the sum of the squared weight allocated to each asset, as used in Blume and Friend (1975) and Nofsinger and Varma (2013) , which measures the portfolio concentration. This variable is analogous to the Herfindahl-Hirschmann Index, which is commonly used to assess industry concentration. The higher the value, the more concentrated the portfolio is; thus, the less diversified it is. Panel C of Table 3 shows that the average sum of the squared allocations is 0.347, a relatively low value that is consistent with diversification. This table displays the sample statistics of the first asset allocation decision task. Panel A shows the expected annual return and volatility of the six assets available (HOME, GROW, BOND, MINE, MMKT, CASH). It also shows the average portfolio allocation to each asset. Panel B shows the frequency with which the given number of assets were selected for each portfolio. Panel C reveals the average expected return selected by the subjects' portfolios. Average Volatility for each portfolio is the sum of the fraction allocated to each asset, multiplied by the volatility of each asset. The average (standard deviation) of this statistic is reported for all the portfolios. The Sum of Squared Allocations is the sum of the squared fraction allocated to each asset. The average and standard deviation of the portfolios are reported. 
Testosterone and cortisol impacts on diversification choices
To examine the relation between hormones and diversification choices, we regress the financial decision on both the testosterone z-scores and cortisol to measure the effect that the two hormones have together. Stanton et al. (2011b) suggest that the relation might include a quadratic testosterone term. Therefore, we estimate a regression model using the testosterone z-score and the squared zscore. Moreover, we include an interaction term between testosterone and a female dummy variable, as it is possible that testosterone does not affect males and females in the same manner as suggested by previous research (Van Anders et al., 2015) . Furthermore, we estimate a regression in which we calculate the raw testosterone levels divided by raw cortisol levels, and then create a z-score of this variable based upon gender distributions to examine the impact of the dual-hormone hypothesis following previous literature (Hermans et al., 2008; Terburg et al., 2009; Van Honk et al., 2010; Barel et al., 2017) . Finally, we include a female gender dummy variable to examine the impact that gender has, as well as control variables of comfort with RIT 2.0, age, and trading experience.
We begin our discussion of the results by examining the expected return selected by the subjects. In Panel A of Table 4 , the expected return selected from the asset allocation is regressed on the hormone level variables. The results show that saliva cortisol levels (Sal-C) coefficient is À0.166 and is significant at the 5% level when examining Sal-C and Sal-T together. Moreover, the coefficients in the expanded model are not significant the testosterone squared z-score, testosterone gender interaction term, gender, and trading experience, but the participants' comfort level with RIT 2.0 is inversely related to expected return. Finally, the Sal-T/Sal-C zscore ratio is insignificant, showing that the dual-hormone hypothesis does not have an impact on investor's expected return. These results show that higher levels of cortisol (or stress) are associated with lower level of expect return.
Panel B of Table 4 shows the relation between average volatility with testosterone and cortisol. The results are similar to the expected return results as the cortisol coefficient is negative and significant. Our results showing that individuals with higher cortisol levels are more risk averse is consistent with the prior literature (Van Honk et al., 2003; Kandasamy et al., 2014) .
Our next analysis examines the influence of testosterone and cortisol on the diversification efforts of the subjects. The diversification variable we employ is the sum of the squared allocations following Blume and Friend (1975) and Nofsinger and Varma (2013) . Panel C of Table 4 examines the effect of the sum of squared allocations, with higher values reflecting a more concentrated portfolio. These results show a positive relationship between the Sal-C and the sum of squared allocations. Therefore, more-stressed subjects select more-concentrated portfolios. The results of these two analyses are consistent in showing that subjects with higher levels of cortisol choose portfolios with lower diversification. Furthermore, these results are consistent with the medical literature showing that higher stress levels are related to a plethora of cognitive errors (McEwen and Sapolsky, 1995; Sapolsky, 1996; Dominique et al., 1998; Lupien et al., 2009 ). Finally, testosterone does not appear to be related to the diversification variables, even when examined under the scope of the dual-hormone hypothesis.
Second diversification task analysis
Financial decisions
After the subjects made their first diversification decision, the simulation produced the yearly returns on their selected portfolio over the 20-year investment period. The subjects then reviewed those asset returns and their final portfolio value. Panel A of Table 5 shows the Expected Return and Volatility of each asset from the first task. Comparing the Expected Return to the Realized Return for each category shows that HOME, BOND, and MINE underperformed by 0.64%, 2.54%, and 1.57%, respectively. GROW outperformed its expectations by an annualized 4.28%. For the subjects, 34 of the 39 portfolios met the goal of generating $1.5 million at the end of the simulation, with an average final portfolio value of $3.8 million. The subjects also reviewed the portfolio values of the other participants and their relative rank. Consider that one participant met the goal with a final portfolio of $1,981,584 and yet was ranked 33rd among the 39 subjects. This adds a competitive aspect to the second task as lower scoring students must improve performance during the second task to increase their rank despite achieving the portfolio goal, which could explain why testosterone was not related to risk taking.
After reviewing the results of the first task, the subjects repeated the portfolio allocation task. The second portfolio allocation task is the same as the first. The trial begins with a $500,000 portfolio with the same goal as before. Since most subjects selected an asset allocation that achieved the goal for the first trial, a reasonable expectation is that they will choose the same allocation in the second task, since all ETF's still have the same distribution of expected return and standard deviation. However, only five of the subjects selected the same allocation for the second task as they did for the first one. These average asset allocation decisions are also provided in Panel A of Table 5 . Comparing these averages to those of the first task shows that the differences in allocations are significant for every asset except for MMKT. The new allocation to CASH is significantly lower, and the other allocations are significantly higher. Therefore, although most subjects met the goal in the first task, they increased allocations to riskier assets for the second trial in order to compete against their classmates instead of focusing on the portfolio value goal.
Panel B of Table 5 provides the distribution of the number of assets selected for the second task. These selections are similar to the distributions in the first task. Panel C of Table 5 shows the new allocation expected return and associated risk. The new expected return is 7.62%, which is significantly larger than the Task 1 expected return of 6.53%. This is consistent with subjects taking more risk during the second task, which is confirmed by the , the number of assets selected in the portfolio (Panel C), and the sum of the squared asset weights (Panel D). Significance is displayed at the 10% (*) and 5% (**) levels with standard errors listed below the coefficients.
significant increase in the average volatility of the portfolios selected. Additionally, the sum of squared allocations is lower in the second task, showing less (average) concentration and more diversification in the portfolios.
Testosterone and cortisol impacts on changes in financial decisions
We next examine the relationship between the decision of asset allocation changes for the second diversification task and testosterone and cortisol levels. Nearly all subjects achieved the portfolio goal in the first task, and the second task is identical, yet the portfolios selected under a competitive environment exhibited a significant increase in expected return. Therefore, we examine whether the change in expected return is related to the hormones in Panel A of Table 6 . Additionally, as it is intuitive that those who achieved lower returns compared to their counterparts will look to take more risk in the second task than in the first task, so we include the annualized rate of return for the subject from the first task in the analysis. The analysis of testosterone and cortisol zscores, as well as the testosterone to cortisol ratio z-scores shows no significance to change in expected return nor change in portfolio volatility. We conclude that a change to a higher risk level for the second task is mostly caused by the subjects' performance in the first task.
Next, we examine the relation of a change in the degree of diversification and the hormones in Panel C of Table 6 . Specifically, we employ the change in the sum of squared allocations as the dependent variable to measure diversification. The results for cortisol are negative and significant with cortisol levels and previous return from diversification task 1 being able to capture 59% of the change in the sum of squared allocations in the model. Overall, the results show that higher levels of stress are associated with changes to more diversified (less concentrated) portfolios.
Lastly, we examine the influence of testosterone and cortisol on the propensity for extrapolation bias (i.e., trend following). The GROW asset has the highest expected return and in the first diversification task it earned the highest return in the simulation. In the second task, all the assets have the same return distribution as in the first task. However, 21 out of 39 subjects increased their allocation to GROW for the second trial in an attempt to increase the returns. Panel D of Table 6 shows the regressions for the change in allocation to GROW. The results show slight gender differences as females with high testosterone to cortisol ratios are more likely to increase their allocation to the Grow asset providing similar results as Panel A.
Rebalancing task analysis
Trading decisions
In the first two trials, subjects completed "set it and forget it" investment tasks. That is, they made asset allocation decisions and then witnessed the 20-year simulation results. In the last trial, the subjects had three opportunities to rebalance their portfolios. Specifically, subjects set their initial allocations exactly as they did in the first two trials. The software then simulates the asset returns for years 1-5. After the fifth year, the subjects can buy and sell assets in order to modify their portfolios to take into consideration their progress to date (REBAL1), even though the expected return and standard deviation for the next years are still the same. The software then simulates the returns for years 6-10. The subjects subsequently can rebalance again (REBAL2). Finally, the subjects rebalance after the returns are known for years 11-15 (REBAL3). The final results are known after the simulation is completed for years 16-20. Examination of the rebalancing task reveals several interesting facts. First, two of the subjects always rebalanced back to their initial percentage asset allocations. The rest rebalanced to different allocations. Fig. 1 shows the return dynamics at each stage of the rebalancing task. The overall allocation decisions required subjects to obtain a 5.65% compounded return over the 20-year period. The portfolios the subjects selected at the outset were expected to earn an average return of 7.38%. After five years of simulated returns, the average realized portfolio return was 5.62%. This means that the portfolios needed to earn 5.67% on average over the next 15 years to achieve the required goal. The average expected return selected This table displays the sample statistics of the second asset allocation decision task. Panel A shows the expected annual return and volatility of the six assets available, which are the same as in Table 3 . It also shows the annualized actual return realized from the first portfolio allocation task. The new average portfolio allocation to each asset is shown with a paired means test with the allocation from the first task. Panel B shows the frequency with which the given number of assets were selected for each portfolio. Panel C displays the average expected return selected by the subjects' portfolios. Average Volatility for each portfolio is the sum of the fraction allocated to each asset multiplied by the volatility of each asset. The average (standard deviation) of this statistic is reported for all the portfolios. The Sum of Squared Allocations is the sum of the squared fraction allocated to each asset. The average and standard deviation of the portfolios are reported. The results of the paired difference in means test is also shown for each variable. Significance is displayed at the 10% (*), 5% (**) and 1% (***) levels with standard errors listed below the coefficients. during REBAL1 was 7.32%. Asset allocation decisions proved even more interesting during REBAL2. The simulated returns for years 6-10 resulted in an average portfolio realized return of 8.60%. This means that subjects only needed to earn an annualized 4.27% during the final 10 years. However, the portfolios selected show an average expected return of 7.21%. Therefore, the average subject took on significantly greater risk than needed in order to achieve the required goal. The subsequent average realized return for years 11-15 was only 1.62%. This result requires an average portfolio return for the final five years of 7.04%. However, subjects selected an average expected return of only 6.69%. Three of the subjects had achieved the $1.5 million final portfolio value at the end of year 15. One of the three reallocated to 88% in the MMKT asset. The other two kept a high level of risk, with the expected return of 8.55% and 9.72%. Consequently, participants as a group did not take on enough risk during the REBAL3 decision point. Overall, subjects do not appear to make large enough changes at decision points REBAL2 and REBAL3 to make up for the prior simulation results, and achieve the overall required goal. We are interested in three aspects of the trading adjustments; adjustments to portfolio risk, the buying or selling of losers, and the buying or selling of winners. The analysis of the adjustments to portfolio risk is an extension of our previous investigation of investment risk. The latter two analyses examine two important investment biases: loss aversion and trend following. This table shows regressions of testosterone and cortisol levels on the changes in risk and return compared to the first allocation decision. Models include the linear level of testosterone and cortisol, a squared testosterone variable, the rate of return from diversification task 1 (D1 ROR), an interaction variable between testosterone and gender, a testosterone to cortisol ratio, an interaction between the testosterone to cortisol ratio and gender, as well as an indicator variable to denote female participants, comfort with RIT 2.0, and trading experience and age. Panel A reports the regression results for five models where the change in expected return is the dependent variable. Changes are measured as the value of the measure in the second decision minus value from the first decision. Results for regressions are also shown for the change in the average volatility of the allocations (Panel B), change in the sum of the squared asset weights (Panel C), and the change in the allocation to the GROW Asset (Panel D). Significance is displayed at the 10% (*), 5% (**) and 1% (***) levels with standard errors listed below the coefficients. Fig. 1 . Average returns during each decision point. This graph shows the average realized portfolio annual return across the 39 portfolios for the five-year simulation periods before each of the three rebalancing decision points. It also shows the average annualized return needed for the balance of the 20-year period to achieve the portfolio value goal. Lastly, the graph shows the average expected return selected by the participants. We begin by examining the risk taken during the four decision points (i.e., initial allocation and the three rebalancing allocations). In addition to the standard measures of risk from the previous tables, we consider various other risk measures and risky choices such as excess expected return. We choose alternative measures because standard measures of risk have been criticized as suboptimal predictors of risk preferences (i.e., Weber et al., 2004) . Risk is defined as the expected return selected with the asset allocation decision minus the return needed to achieve the final portfolio goal, which we call Excess Expected Return. That is, during the initial allocation, subjects need to achieve a 5.65% return annually to achieve the required goal. The excess expected return is the expected return of the portfolio less 5.65%, which measures the extent to which subjects are more competitiveoriented than goal-oriented, given that returns in excess of the required 5.65% is a measure of unnecessary risk taking. After the first five years of simulated returns, the subjects observe their realized returns, and can adjust their allocations accordingly in order to meet the required goal. For instance, if the portfolio return was only 4% annually, the subject would need a compounded 6.2% return for the remaining 15 years to achieve the required goal. For the said subject, we would compute the excess expected return at the REBAL1 decision as the expected return from the rebalanced portfolio less 6.2%. Similarly, we compute the excess expected return at the REBAL2 and REBAL3 decision points. Therefore, we have 156 data points (39 subjects Â 4 decision points) for this analysis.
Panel A of Table 7 shows a regression model of the Excess Expected Return on both hormones, testosterone squared z-scores, gender, comfort with RIT 2.0, trading experience, age, and three dummy variables for the three rebalancing decision points. The results show that the Sal-T coefficient is significantly positive, and Sal-C is negative and significant. These results show that higher levels of testosterone are positively associated with unnecessary levels of risk taking than are required to reach the goal, which is consistent with Eisenegger et al. (2011) who show that testosterone promotes competition and status-seeking, whereas cortisol is inversely related, which is consistent with previously mentioned medical studies. Moreover, the results show that the interaction between testosterone and the female dummy variable are negative and significant showing that higher testosterone levels have different effects on excess expected returns depending on gender. Finally, the Sal-T/Sal-C ratio coefficient is positive and significant, showing that the dual-hormone hypothesis is related to excess expected return during a competitive economic environment, with the results showing significant gender differences. As mentioned, earlier, previous medical studies have shown that the dualhormone hypothesis is an important factor during social risktaking tasks. To our knowledge, this is the first study showing the dual hormone hypothesis relation to financial risk taking.
Next, we examine loss aversion by analyzing the re-allocations after an asset class loses money during any five-year simulation period. Two instances exist when an asset has a negative return during the first five-year simulation; namely, the BOND and MINE assets earned an annual compounded return of À0.75% and À4.48%, respectively. We examine whether subjects bought, sold, or simply held the asset immediately after these poor returns.
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Subjects had 76 decisions to buy/sell/hold these two losing assets, 19 subjects decided to sell shares and 57 subjects decided to purchase shares. These results are inconsistent with the disposition effect (Odean, 1998) , which is the result of loss aversion. The disposition effect predicts that investors will hold losing positions in order to avoid the feeling of regret from realizing the loss. However, in this trial, a majority of participants bought more of the losing asset rather than simply holding on to their current position. We explain this finding by noting that this task focuses on portfolio issues like asset allocation, portfolio risk, and portfolio expected return to meet a final required portfolio value goal. In other words, this task is framed to focus more on the portfolio and less on individual assets. Lim and Kumar (2008) show that the disposition effect is greater when subjects are narrowly focused. Therefore, the broad focus of the portfolio level may not be conducive to the disposition effect.
Panel B of Table 7 shows the regression of the amount transacted (positive values are buys and negative values are sells) at REBAL1 for the two losing assets. The dependent variable is the amount bought or sold as a percentage of the starting portfolio value. The results show that stress is positively related to buying losing ETFs as higher stressed subjects may be trying to double down to avoid losses. Testosterone is negatively related to buying losers especially in females Similarly, subjects with a higher testosterone to cortisol ratio have a negative and significant impact on buying losers, predominantly in females. These results show Testosterone and cortisol levels are examined in relation to trading decisions in the rebalancing exercise. Models include the linear level of testosterone and cortisol, a squared testosterone variable, an interaction variable between testosterone and gender, a testosterone to cortisol ratio, an interaction between the testosterone to cortisol ratio and gender, as well as an indicator variable to denote female participants, comfort with RIT 2.0, and trading experience and age. Panel A reports the OLS regression for Excess Expected Return (N = 156). Excess Expected Return is the expected return selected minus the return needed to meet the final accumulation goal. Panel B reports the regression for the asset allocation change for assets that lost money during the previous five years (N = 76). Panel C reports the regression results for the allocation change to the asset with the highest return from the previous five-year period (N = 117). Significance is displayed at the 20% (#), 10% (*), 5% (**) and 1% (***) levels with standard errors listed below the coefficients.
that the dual-hormone hypothesis is related to loss aversion, and the disposition effect, and that individuals with high testosterone and low cortisol levels are more likely to sell losing stocks demonstrating less loss aversion. Lastly, we examine the buying or selling of the best-performing asset in the five-year period subsequent to the next rebalancing decision. The best performing asset during years 1-5 of the simulation was HOME, with a 14.98% annualized return. The GROW asset has the highest returns for years 6-10 and years 11-15, with returns of 12.92% and 5.50%, respectively. There are 117 decisions to buy/sell/hold these winners (39 portfolios Â 3 rebalance decisions). For the instances of holding a winner asset, 20 of the subjects purchased more and 93 sold at least some shares. Clearly, most of the subjects did not exhibit a trend-following behavior. Instead, they decided to sell some of the winner assets to allocate money to the other assets. We estimate our regression model using these transactions for the winner assets. Panel C of Table 7 shows no significant coefficients for the variables of interest.
Impact of investment outcomes on testosterone and cortisol
Most studies that focus on behavioral finance explore the impact of irrational psychological influences on trades and portfolio positions. Some of the most studied examples include the disposition effect (Lim and Kumar, 2008) , home bias (Coval and Moskowitz, 1999) , and overconfidence (Hilary and Menzly, 2006) . The literature suggests that environment can impact investor sentiment and influence stock markets, even if no rational (i.e., non-emotional) association exists. A few examples that demonstrate the relevance of emotions during financial decisions are sporting event outcomes (Edmans et al., 2007) , sunshine duration (Hirshleifer and Shumway, 2004) , and the winter blues (Kamstra et al., 2000) . However, very few papers explore the relationship in the opposite direction. That is, does the stock market impact investor physiology? One notable exception is Engelberg and Parsons (2016) , who find a link between hospital admissions after large stock market declines.
Biologists also have discovered that male primates (including humans) experience elevated levels of testosterone during situations of physical challenge. For example, athletes show increased testosterone levels during competition, and testosterone levels increase further after winning an event (Gladue et al., 1989) . Therefore, winning and losing contests could impact a person's hormone levels.
After the final simulation, the results of the third task were known, our subjects contributed another saliva sample for testosterone and cortisol testing. We converted their testosterone levels to z-scores and use their actual cortisol levels just as done with the initial benchmark sample, and computed the change in hormones from this end-of-experiment measurement to the beginning measurement. The subjects saw their final portfolio results as well as a performance ranking for all the subjects. Therefore, the rebalancing task produced two outcomes: the final portfolio value and the ranking among the other subjects. The simulated return during years 16-20 were poor; the outcome being that only seven out of the 39 subjects met the final required portfolio goal. We employ two variables that capture the level of success of the subjects. The first is the total return realized during the rebalancing task. This variable has a competitive nature to it, as it allows a ranking with the other subjects. The second is a dummy variable of 1 for subjects who met the final portfolio goal. Furthermore, we include a female interaction term with the subjects' success, as research shows that change in hormones due to competition may have gender differences (Kivlighan et al., 2005) . Table 8 reports regressions where the dependent variables are the changes in testosterone (Panel A) and the changes in cortisol (Panel B). The independent variables are the Total Return or Met Goal dummy variables. The results show that the coefficient for Total Return is positive and significant at the 5% level for testosterone with females displaying a greater effect as the interaction term between total return and the female dummy variable is positive. Similarly, the results show a positive coefficient for Met Goal, however the results are insignificant likely due to the limited binary outcomes. The results show that doing well in a competitive financial environment increases the subject's testosterone, which is consistent with the literature mentioned earlier regarding social tasks. The insignificant results for the change in cortisol show that higher total return is related to higher stress, with the female interaction term having a positive coefficient once again. Furthermore, meeting the required goal is also associated with higher cortisol levels. We interpret these results as direct evidence that the outcomes of investing decisions can impact the hormone level of investors during competitive financial environments, which in turn should influence future financial decisions as evidence by previous results.
Discussion and conclusions
What is the role of testosterone and cortisol in financial investing and speculation? What is the role of taking risk and competing in relation to the level of testosterone and cortisol? Our This table reports the impact that trading has on the hormone levels of the subjects. The subjects' testosterone and cortisol levels were measured after the rebalancing exercise and compared to the pre-event measurement. The change in testosterone (Panel A) and change in cortisol (Panel B) are regressed on final rebalancing results. Specifically, the final rebalancing results are measured as the total return earned over the 20-year simulation and a dummy variable stating whether the financial goal was met or not. Significance is displayed at the 10% (*) and 5% (**) levels with standard errors listed below the coefficients. N = 39.
evidence shows that these relations are dynamic throughout the trading process. At the beginning of the first task, the subjects set their asset allocation decisions in the first diversification trial. The results show a negative relation between cortisol levels with the financial risk taken. We also find that cortisol is inversely related with the level of portfolio diversification. Finally, the ratio of testosterone to cortisol is insignificant in all diversification tasks, regardless of the measure used.
Our last task involves a series of rebalancing choices, which increases the competition between the subjects as they observe their rank compared to other subjects after each rebalancing time period. We examine the level of risk taken at each of the four decision points in this task by comparing the expected return selected to the return needed to achieve the portfolio value goal. We find that higher testosterone levels are associated with selecting portfolios with higher risk than required to meet the investment goals, while cortisol levels are inversely related. These results are consistent with the hypothesis that subjects with higher testosterone levels possess personal goals to perform well compared to their peers. Additionally, subjects with a higher testosterone to cortisol ratio report higher excess expected returns in males. Furthermore, in accordance with the dual-hormone hypothesis, subjects with higher testosterone to cortisol ratios are more likely to sell losing ETF's, especially in females, showing that it is inversely linked to loss aversion. This is the first study documenting the impact of the dual-hormone hypothesis in the financial decision-making process.
Finally, we find that the results of the final rebalancing task influence the hormone level of the subjects. The higher the total return achieved, the greater the change in testosterone. As previously mentioned, studies similar to ours suggest that there is a link between the psychology, sentiment, and/or physiology of investors and their subsequent trading choices. Yet, only a handful of studies show the reverse relationship (i.e., whether investment decisions impact the psychology, sentiment, and/or physiology of investors). This is a significant contribution, since the vast majority of models of the stock market ignore the important feedback loop between investor physiology and financial decision-making and outcomes. Shiller (2002) argues that speculative bubbles form because of a feedback loop in which optimistic investors bid up prices. The increased prices subsequently cause investors to be more optimistic and to buy more stocks, perpetuating the cycle. This study provides clear evidence for Shiller's (2002) hypothesis that "winning" in the stock market increases testosterone, which in turn increases the investment risk undertaken by the investor. Therefore, as investors have portfolio success their testosterone levels increase, which according to our results will further increase subjects risk taking and will continue in this cycle.
